Skip to main content
Erschienen in: Journal of Nephrology 5/2023

18.01.2023 | Original Article

Prevalence of chronic kidney disease in women of reproductive age and observed birth rates

verfasst von: Willemijn A. L. Vrijlandt, Margriet F. C. de Jong, Jelmer R. Prins, Kate Bramham, Patrick J. W. S. Vrijlandt, Roemer J. Janse, Faizan Mazhar, Juan Jesús Carrero

Erschienen in: Journal of Nephrology | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Women of reproductive age with chronic kidney disease (CKD) are recognised to have decreased fertility and a higher risk of adverse pregnancy outcomes. How often CKD afflicts women of reproductive age is not well known. This study aimed to evaluate the burden of CKD and associated birth rates in an entire region.

Methods

This was a retrospective cohort study including women of childbearing age in Stockholm during 2006–2015. We estimated the prevalence of “probable CKD” by the presence of an ICD-10 diagnosis of CKD, a single estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 or history of maintenance dialysis. By linkage with the Swedish Medical Birth Register we identified births during the subsequent three years from study inclusion and evaluated birth rates.

Results

We identified 817,730 women in our region, of whom 55% had at least one creatinine measurement. A total of 3938 women were identified as having probable CKD, providing an age-averaged CKD prevalence of 0.50%. Women with probable CKD showed a lower birth rate 3 years after the index date (35.7 children per 1000 person years) than the remaining women free from CKD (46.5 children per 1000 person years).

Conclusion

As many as 0.50% of individuals in this cohort had probable CKD, defined on the basis of at least one eGFR<60 ml/min1.73 m2 test result, dialysis treatment (i.e. CKD stages 3–5) or an ICD-10 diagnosis of CKD. This prevalence is lower than previous estimates. Women with probable CKD, according to a study mainly capturing CKD 3–5, had a lower birth rate than those without CKD, illustrating the challenges of this population to successfully conceive.

Graphical Abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M et al (2016) A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on kidney and pregnancy. J Nephrol 29:277–303CrossRefPubMedPubMedCentral Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M et al (2016) A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on kidney and pregnancy. J Nephrol 29:277–303CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Wiles KS, Nelson-Piercy C, Bramham K (2018) Reproductive health and pregnancy in women with chronic kidney disease. Nat Rev Nephrol 14:165–184CrossRefPubMed Wiles KS, Nelson-Piercy C, Bramham K (2018) Reproductive health and pregnancy in women with chronic kidney disease. Nat Rev Nephrol 14:165–184CrossRefPubMed
3.
Zurück zum Zitat Oliverio AL, Bramham K, Hladunewich MA (2021) Pregnancy and CKD: advances in care and the legacy of Dr Susan Hou. Am J Kidney Dis 78:865–875CrossRefPubMed Oliverio AL, Bramham K, Hladunewich MA (2021) Pregnancy and CKD: advances in care and the legacy of Dr Susan Hou. Am J Kidney Dis 78:865–875CrossRefPubMed
4.
Zurück zum Zitat Oliverio AL, Admon LK, Mariani LH, Winkelman TNA, Dalton VK (2020) Health outcomes and health care utilization among obstetric deliveries with concurrent CKD in the United States. Am J Kidney Dis 75:148–150CrossRefPubMed Oliverio AL, Admon LK, Mariani LH, Winkelman TNA, Dalton VK (2020) Health outcomes and health care utilization among obstetric deliveries with concurrent CKD in the United States. Am J Kidney Dis 75:148–150CrossRefPubMed
5.
6.
Zurück zum Zitat Wiles K, Webster P, Seed PT, Bennett-Richards K, Bramham K, Brunskill N et al (2020) The impact of chronic kidney disease stages 3–5 on pregnancy outcomes. Nephrol Dial Transplant 36:2008–2017CrossRefPubMedCentral Wiles K, Webster P, Seed PT, Bennett-Richards K, Bramham K, Brunskill N et al (2020) The impact of chronic kidney disease stages 3–5 on pregnancy outcomes. Nephrol Dial Transplant 36:2008–2017CrossRefPubMedCentral
7.
Zurück zum Zitat Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P et al (2016) Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89:874–885CrossRefPubMed Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P et al (2016) Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89:874–885CrossRefPubMed
8.
Zurück zum Zitat Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N et al (2015) Risk of adverse pregnancy outcomes in women with CKD. JASN 26:2011–2022CrossRefPubMedPubMedCentral Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N et al (2015) Risk of adverse pregnancy outcomes in women with CKD. JASN 26:2011–2022CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M et al (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 395:709–733CrossRef Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M et al (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 395:709–733CrossRef
10.
Zurück zum Zitat Piccoli GB, Alrukhaimi M, Liu Z-H, Zakharova E, Levin A, Li PKT et al (2018) Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int 93:278–283CrossRefPubMed Piccoli GB, Alrukhaimi M, Liu Z-H, Zakharova E, Levin A, Li PKT et al (2018) Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int 93:278–283CrossRefPubMed
11.
Zurück zum Zitat Piccoli GB, Zakharova E, Attini R, Ibarra Hernandez M, Orozco Guillien A, Alrukhaimi M et al (2018) Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med. 7:415CrossRefPubMedPubMedCentral Piccoli GB, Zakharova E, Attini R, Ibarra Hernandez M, Orozco Guillien A, Alrukhaimi M et al (2018) Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med. 7:415CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D’Amico F et al (2010) Pregnancy and chronic kidney disease: a challenge in all CKD stages. CJASN 5:844–855CrossRefPubMedPubMedCentral Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D’Amico F et al (2010) Pregnancy and chronic kidney disease: a challenge in all CKD stages. CJASN 5:844–855CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Siekierka-Harreis M, Rump LC (2011) Schwangerschaft und Nierenerkrankungen. Internist 52:1167–1177CrossRefPubMed Siekierka-Harreis M, Rump LC (2011) Schwangerschaft und Nierenerkrankungen. Internist 52:1167–1177CrossRefPubMed
14.
Zurück zum Zitat Du Y, Zhang S, Hu M, Wang Q, Shen H, Zhang Y et al (2017) Prevalence of chronic kidney disease markers: evidence from a three-million married population with fertility desire in rural China. Sci Rep 7:2710CrossRefPubMedPubMedCentral Du Y, Zhang S, Hu M, Wang Q, Shen H, Zhang Y et al (2017) Prevalence of chronic kidney disease markers: evidence from a three-million married population with fertility desire in rural China. Sci Rep 7:2710CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Maule SP, Ashworth DC, Blakey H, Osafo C, Moturi M, Chappell LC et al (2020) CKD and pregnancy outcomes in Africa: a narrative review. Kidney Int Rep 5:1342–1349CrossRefPubMedPubMedCentral Maule SP, Ashworth DC, Blakey H, Osafo C, Moturi M, Chappell LC et al (2020) CKD and pregnancy outcomes in Africa: a narrative review. Kidney Int Rep 5:1342–1349CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Mills KT, Xu Y, Zhang W, Bundy JD, Chen C-S, Kelly TN et al (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88:950–957CrossRefPubMedPubMedCentral Mills KT, Xu Y, Zhang W, Bundy JD, Chen C-S, Kelly TN et al (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88:950–957CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Webster P, Lightstone L, McKay DB, Josephson MA (2017) Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int 91:1047–1056CrossRefPubMed Webster P, Lightstone L, McKay DB, Josephson MA (2017) Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int 91:1047–1056CrossRefPubMed
19.
Zurück zum Zitat Axelsson O (2003) The Swedish medical birth register. Acta Obstetr Gynecol Scand 82:491–492CrossRef Axelsson O (2003) The Swedish medical birth register. Acta Obstetr Gynecol Scand 82:491–492CrossRef
22.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Iii AFC, Feldman HI, Kusek JW et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Iii AFC, Feldman HI, Kusek JW et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
23.
24.
Zurück zum Zitat Piccoli GB, Cabiddu G, Daidone G, Guzzo G, Maxia S, Ciniglio I et al (2014) The children of dialysis: live-born babies from on-dialysis mothers in Italy—an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol Dial Transplant 29:1578–1586CrossRefPubMed Piccoli GB, Cabiddu G, Daidone G, Guzzo G, Maxia S, Ciniglio I et al (2014) The children of dialysis: live-born babies from on-dialysis mothers in Italy—an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol Dial Transplant 29:1578–1586CrossRefPubMed
25.
Zurück zum Zitat Kulu H, Vikat A, Andersson G (2007) Settlement size and fertility in the Nordic countries. Popul Stud 61:265–285CrossRef Kulu H, Vikat A, Andersson G (2007) Settlement size and fertility in the Nordic countries. Popul Stud 61:265–285CrossRef
Metadaten
Titel
Prevalence of chronic kidney disease in women of reproductive age and observed birth rates
verfasst von
Willemijn A. L. Vrijlandt
Margriet F. C. de Jong
Jelmer R. Prins
Kate Bramham
Patrick J. W. S. Vrijlandt
Roemer J. Janse
Faizan Mazhar
Juan Jesús Carrero
Publikationsdatum
18.01.2023
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 5/2023
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-022-01546-z

Weitere Artikel der Ausgabe 5/2023

Journal of Nephrology 5/2023 Zur Ausgabe

Lessons for the Clinical Nephrologist

Acute kidney injury following methotrexate treatment

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.